Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reisa Sperling

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Neurology|July 3, 2020
Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriersEdmarie Guzmán-Vélez, Jairo Martínez, Kate Papp, et al.
Nature Communications|June 6, 2024
Tau propagation in the brain olfactory circuits is associated with smell perception changes in agingIbai Diez, Laura Ortiz-Terán, Thomas S C Ng, et al.
JAMA Network Open|March 30, 2026
Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological DistressJoshua D Grill, Rema Raman, Shunran Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2016
Implementation of subjective cognitive decline criteria in research studiesJosé L Molinuevo, Laura A Rabin, Rebecca Amariglio, et al.
JAMA Neurology|January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical TrialReisa Sperling, David Henley, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupClifford R Jack, J Scott Andrews, Thomas G Beach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 15, 2018
NIA-AA Research Framework: Toward a biological definition of Alzheimer's diseaseClifford R Jack, David A Bennett, Kaj Blennow, et al.
The Lancet. Neurology|February 7, 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysisReisa Sperling, Stephen Salloway, David J Brooks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.
Annals of Neurology|October 28, 2015
Tau positron emission tomographic imaging in aging and early Alzheimer diseaseKeith A Johnson, Aaron Schultz, Rebecca A Betensky, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Neurology|July 3, 2020
Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriersEdmarie Guzmán-Vélez, Jairo Martínez, Kate Papp, et al.
Nature Communications|June 6, 2024
Tau propagation in the brain olfactory circuits is associated with smell perception changes in agingIbai Diez, Laura Ortiz-Terán, Thomas S C Ng, et al.
JAMA Network Open|March 30, 2026
Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological DistressJoshua D Grill, Rema Raman, Shunran Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2016
Implementation of subjective cognitive decline criteria in research studiesJosé L Molinuevo, Laura A Rabin, Rebecca Amariglio, et al.
JAMA Neurology|January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical TrialReisa Sperling, David Henley, Paul S Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupClifford R Jack, J Scott Andrews, Thomas G Beach, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 15, 2018
NIA-AA Research Framework: Toward a biological definition of Alzheimer's diseaseClifford R Jack, David A Bennett, Kaj Blennow, et al.
The Lancet. Neurology|February 7, 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysisReisa Sperling, Stephen Salloway, David J Brooks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.
Annals of Neurology|October 28, 2015
Tau positron emission tomographic imaging in aging and early Alzheimer diseaseKeith A Johnson, Aaron Schultz, Rebecca A Betensky, et al.
Pageof 10